Literature DB >> 2415056

Tick-borne relapsing fever in a premature infant.

D Brasseur.   

Abstract

Relapsing fever is caused by the Borrelia species of spirochetes. Louse-born epidemics of the disease may occur but the endemic disease is usually transmitted to humans by the bite of an infected tick (Ornithodorus). Transplacental infection was suggested more than 75 years ago (1) but has been rarely documented (2). We describe a case of neonatal relapsing fever where maternal infection was the probable cause of the premature delivery and infection in the infant.

Entities:  

Mesh:

Year:  1985        PMID: 2415056     DOI: 10.1080/02724936.1985.11748384

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  6 in total

1.  Oms38 is the first identified pore-forming protein in the outer membrane of relapsing fever spirochetes.

Authors:  Marcus Thein; Ignas Bunikis; Katrin Denker; Christer Larsson; Sally Cutler; Michel Drancourt; Tom G Schwan; Reinhard Mentele; Friedrich Lottspeich; Sven Bergström; Roland Benz
Journal:  J Bacteriol       Date:  2008-08-29       Impact factor: 3.490

Review 2.  Pathogenesis of Relapsing Fever.

Authors:  Job Lopez; Joppe W Hovius; Sven Bergström
Journal:  Curr Issues Mol Biol       Date:  2020-12-29       Impact factor: 2.081

Review 3.  Relapsing Fevers: Neglected Tick-Borne Diseases.

Authors:  Emilie Talagrand-Reboul; Pierre H Boyer; Sven Bergström; Laurence Vial; Nathalie Boulanger
Journal:  Front Cell Infect Microbiol       Date:  2018-04-04       Impact factor: 5.293

Review 4.  Vector-borne diseases in pregnancy.

Authors:  Brendan O'Kelly; John S Lambert
Journal:  Ther Adv Infect Dis       Date:  2020-09-01

5.  Tick borne relapsing fever - a systematic review and analysis of the literature.

Authors:  Ákos Jakab; Pascal Kahlig; Esther Kuenzli; Andreas Neumayr
Journal:  PLoS Negl Trop Dis       Date:  2022-02-16

Review 6.  An Overview of Tickborne Infections in Pregnancy and Outcomes in the Newborn: The Need for Prospective Studies.

Authors:  John S Lambert
Journal:  Front Med (Lausanne)       Date:  2020-03-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.